Related Experiment Video

Updated: Oct 20, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K

Clinical overview for pediatric population with SARS-CoV-2 and care: review

Lucas Amaral Martins1,2, Deisy Vital Dos Santos1, Patrícia Figueiredo Marques1

  • 1Universidade Federal do Recôncavo da Bahia (UFRB), Centro de Ciências da Saúde, Colegiado de Enfermagem. Santo Antônio de Jesus, Bahia, Brasil.

Revista Gaucha De Enfermagem
|September 15, 2021
PubMed

Insights

Pediatric COVID-19 cases present varied symptoms, including respiratory issues, gastrointestinal problems, and fever. Early screening and extended isolation are recommended for infected children and their families.

Area of Science:

  • Pediatric infectious diseases
  • Public health surveillance
  • Viral respiratory illnesses

Background:

  • The global emergence of SARS-CoV-2 has necessitated understanding its impact on pediatric populations.
  • Limited data exists on the clinical spectrum and management of COVID-19 in children.

Purpose of the Study:

  • To synthesize the clinical presentation of SARS-CoV-2 positive children.
  • To identify recommended care and isolation strategies for pediatric COVID-19 cases.

Main Methods:

  • A rapid review methodology was employed, adhering to Joanna Briggs Institute guidelines.
  • A comprehensive literature search was conducted across nine databases in April 2020.
  • Eighteen primary studies were critically appraised and synthesized.

Main Results:

  • Common clinical findings included respiratory symptoms, gastrointestinal issues, and fever.
  • Radiological findings often showed irregular ground-glass opacifications.
  • Screening of symptomatic pediatric cases and family members, along with isolation exceeding 14 days, was advised.

Conclusions:

  • Pediatric COVID-19 presents a diverse clinical picture, not limited to respiratory symptoms, with a notable proportion of asymptomatic individuals.
  • Further research, including randomized controlled trials and cohort studies, is crucial to elucidate the role of children in COVID-19 transmission.
Abstract

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.5K
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.1K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
34
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
44
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
40
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
526
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
39